Advanced Solution for Targeted Next Generation Sequencing (NGS) of Circulating Cell-Free Tumor DNA.
ctDNA (Circulating Tumor DNA) consist of only a small fraction of cfDNA (Cell Free DNA). ctDNA mutations detected with high sensitivity of low-allelic frequency (AF) down to 0.01%. ctDNA libraries for NGS can be prepared, sequenced and analyzed relatively fast.
